Performance of an IS6110-Based PCR Assay and the COBAS AMPLICOR MTB PCR System for Detection of Mycobacterium tuberculosis Complex DNA in Human Lymph Node Samples
AUTOR(ES)
Rimek, Dagmar
FONTE
American Society for Microbiology
RESUMO
We compared the performance of two PCR assays, an IS6110-based in-house protocol and the COBAS AMPLICOR MTB PCR (COBAS MTB) system, for the detection of Mycobacterium tuberculosis complex in 43 human lymph node samples from 40 patients. For the in-house PCR and the COBAS MTB assays, respectively, sensitivities were 87.5% versus 45.5% (P < 0.05), specificities were 100.0% versus 91.3% (P > 0.05), and inhibition rates were 4.8% versus 19.5% (P < 0.05). For the COBAS MTB system, additional N-acetyl-l-cysteine-NaOH pretreatment of the samples changed neither the inhibition rate nor the sensitivity significantly.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=120681Documentos Relacionados
- IS6110-based PCR methods for detection of Mycobacterium tuberculosis.
- Specificity of IS6110-Based DNA Fingerprinting and Diagnostic Techniques for Mycobacterium tuberculosis Complex
- Specificity of IS6110-based amplification assays for Mycobacterium tuberculosis complex.
- Specificity of IS6110-based amplification assays for Mycobacterium tuberculosis complex.
- Comparison of Roche Cobas Amplicor Mycobacterium tuberculosis Assay with In-House PCR and Culture for Detection of M. tuberculosis
